注射ペプチド薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Injection Peptide Drug Market Insights, Forecast to 2028

• レポートコード：QY2207E10389 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の注射ペプチド薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に注射ペプチド薬の世界市場のxxx％を占める「静脈内注射」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「がん」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の注射ペプチド薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの注射ペプチド薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの注射ペプチド薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 注射ペプチド薬のグローバル主要メーカーには、Sanofi、Teva、Novo Nordisk、Takeda、Eli Lilly、AstraZeneca、Novartis、AbbVie、Ipsen、Ferring、Merck、The Medicines、J & Jなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射ペプチド薬市場は、種類と用途によって区分されます。世界の注射ペプチド薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 静脈内注射、皮下注射 【用途別セグメント】 がん、代謝障害、中枢神経系、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射ペプチド薬製品概要 - 種類別市場（静脈内注射、皮下注射） - 用途別市場（がん、代謝障害、中枢神経系、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射ペプチド薬販売量予測2017-2028 - 世界の注射ペプチド薬売上予測2017-2028 - 注射ペプチド薬の地域別販売量 - 注射ペプチド薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射ペプチド薬販売量 - 主要メーカー別注射ペプチド薬売上 - 主要メーカー別注射ペプチド薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（静脈内注射、皮下注射） - 注射ペプチド薬の種類別販売量 - 注射ペプチド薬の種類別売上 - 注射ペプチド薬の種類別価格 ・用途別市場規模（がん、代謝障害、中枢神経系、その他） - 注射ペプチド薬の用途別販売量 - 注射ペプチド薬の用途別売上 - 注射ペプチド薬の用途別価格 ・北米市場 - 北米の注射ペプチド薬市場規模（種類別、用途別） - 主要国別の注射ペプチド薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射ペプチド薬市場規模（種類別、用途別） - 主要国別の注射ペプチド薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射ペプチド薬市場規模（種類別、用途別） - 主要国別の注射ペプチド薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射ペプチド薬市場規模（種類別、用途別） - 主要国別の注射ペプチド薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射ペプチド薬市場規模（種類別、用途別） - 主要国別の注射ペプチド薬市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、Teva、Novo Nordisk、Takeda、Eli Lilly、AstraZeneca、Novartis、AbbVie、Ipsen、Ferring、Merck、The Medicines、J & J ・産業チェーン及び販売チャネル分析 - 注射ペプチド薬の産業チェーン分析 - 注射ペプチド薬の原材料 - 注射ペプチド薬の生産プロセス - 注射ペプチド薬の販売及びマーケティング - 注射ペプチド薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射ペプチド薬の産業動向 - 注射ペプチド薬のマーケットドライバー - 注射ペプチド薬の課題 - 注射ペプチド薬の阻害要因 ・主な調査結果

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
Market Analysis and Insights: Global Injection Peptide Drug Market
The global Injection Peptide Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Intravenous Injection accounting for % of the Injection Peptide Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period.
China Injection Peptide Drug market size is valued at US$ million in 2021, while the North America and Europe Injection Peptide Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Injection Peptide Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injection Peptide Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injection Peptide Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injection Peptide Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injection Peptide Drug market.
Global Injection Peptide Drug Scope and Market Size
Injection Peptide Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Injection Peptide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Intravenous Injection
Subcutaneous Injection
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injection Peptide Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Intravenous Injection
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Injection Peptide Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Injection Peptide Drug Market Perspective (2017-2028)
2.2 Injection Peptide Drug Growth Trends by Region
2.2.1 Injection Peptide Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Injection Peptide Drug Historic Market Size by Region (2017-2022)
2.2.3 Injection Peptide Drug Forecasted Market Size by Region (2023-2028)
2.3 Injection Peptide Drug Market Dynamics
2.3.1 Injection Peptide Drug Industry Trends
2.3.2 Injection Peptide Drug Market Drivers
2.3.3 Injection Peptide Drug Market Challenges
2.3.4 Injection Peptide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injection Peptide Drug Players by Revenue
3.1.1 Global Top Injection Peptide Drug Players by Revenue (2017-2022)
3.1.2 Global Injection Peptide Drug Revenue Market Share by Players (2017-2022)
3.2 Global Injection Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injection Peptide Drug Revenue
3.4 Global Injection Peptide Drug Market Concentration Ratio
3.4.1 Global Injection Peptide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injection Peptide Drug Revenue in 2021
3.5 Injection Peptide Drug Key Players Head office and Area Served
3.6 Key Players Injection Peptide Drug Product Solution and Service
3.7 Date of Enter into Injection Peptide Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injection Peptide Drug Breakdown Data by Type
4.1 Global Injection Peptide Drug Historic Market Size by Type (2017-2022)
4.2 Global Injection Peptide Drug Forecasted Market Size by Type (2023-2028)
5 Injection Peptide Drug Breakdown Data by Application
5.1 Global Injection Peptide Drug Historic Market Size by Application (2017-2022)
5.2 Global Injection Peptide Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Injection Peptide Drug Market Size (2017-2028)
6.2 North America Injection Peptide Drug Market Size by Type
6.2.1 North America Injection Peptide Drug Market Size by Type (2017-2022)
6.2.2 North America Injection Peptide Drug Market Size by Type (2023-2028)
6.2.3 North America Injection Peptide Drug Market Share by Type (2017-2028)
6.3 North America Injection Peptide Drug Market Size by Application
6.3.1 North America Injection Peptide Drug Market Size by Application (2017-2022)
6.3.2 North America Injection Peptide Drug Market Size by Application (2023-2028)
6.3.3 North America Injection Peptide Drug Market Share by Application (2017-2028)
6.4 North America Injection Peptide Drug Market Size by Country
6.4.1 North America Injection Peptide Drug Market Size by Country (2017-2022)
6.4.2 North America Injection Peptide Drug Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Injection Peptide Drug Market Size (2017-2028)
7.2 Europe Injection Peptide Drug Market Size by Type
7.2.1 Europe Injection Peptide Drug Market Size by Type (2017-2022)
7.2.2 Europe Injection Peptide Drug Market Size by Type (2023-2028)
7.2.3 Europe Injection Peptide Drug Market Share by Type (2017-2028)
7.3 Europe Injection Peptide Drug Market Size by Application
7.3.1 Europe Injection Peptide Drug Market Size by Application (2017-2022)
7.3.2 Europe Injection Peptide Drug Market Size by Application (2023-2028)
7.3.3 Europe Injection Peptide Drug Market Share by Application (2017-2028)
7.4 Europe Injection Peptide Drug Market Size by Country
7.4.1 Europe Injection Peptide Drug Market Size by Country (2017-2022)
7.4.2 Europe Injection Peptide Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injection Peptide Drug Market Size (2017-2028)
8.2 Asia-Pacific Injection Peptide Drug Market Size by Type
8.2.1 Asia-Pacific Injection Peptide Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Injection Peptide Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Injection Peptide Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific Injection Peptide Drug Market Size by Application
8.3.1 Asia-Pacific Injection Peptide Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Injection Peptide Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Injection Peptide Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific Injection Peptide Drug Market Size by Region
8.4.1 Asia-Pacific Injection Peptide Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Injection Peptide Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Injection Peptide Drug Market Size (2017-2028)
9.2 Latin America Injection Peptide Drug Market Size by Type
9.2.1 Latin America Injection Peptide Drug Market Size by Type (2017-2022)
9.2.2 Latin America Injection Peptide Drug Market Size by Type (2023-2028)
9.2.3 Latin America Injection Peptide Drug Market Share by Type (2017-2028)
9.3 Latin America Injection Peptide Drug Market Size by Application
9.3.1 Latin America Injection Peptide Drug Market Size by Application (2017-2022)
9.3.2 Latin America Injection Peptide Drug Market Size by Application (2023-2028)
9.3.3 Latin America Injection Peptide Drug Market Share by Application (2017-2028)
9.4 Latin America Injection Peptide Drug Market Size by Country
9.4.1 Latin America Injection Peptide Drug Market Size by Country (2017-2022)
9.4.2 Latin America Injection Peptide Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injection Peptide Drug Market Size (2017-2028)
10.2 Middle East & Africa Injection Peptide Drug Market Size by Type
10.2.1 Middle East & Africa Injection Peptide Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Injection Peptide Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Injection Peptide Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa Injection Peptide Drug Market Size by Application
10.3.1 Middle East & Africa Injection Peptide Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Injection Peptide Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Injection Peptide Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa Injection Peptide Drug Market Size by Country
10.4.1 Middle East & Africa Injection Peptide Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Injection Peptide Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injection Peptide Drug Introduction
11.1.4 Sanofi Revenue in Injection Peptide Drug Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Injection Peptide Drug Introduction
11.2.4 Teva Revenue in Injection Peptide Drug Business (2017-2022)
11.2.5 Teva Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Injection Peptide Drug Introduction
11.3.4 Novo Nordisk Revenue in Injection Peptide Drug Business (2017-2022)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Injection Peptide Drug Introduction
11.4.4 Takeda Revenue in Injection Peptide Drug Business (2017-2022)
11.4.5 Takeda Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Injection Peptide Drug Introduction
11.5.4 Eli Lilly Revenue in Injection Peptide Drug Business (2017-2022)
11.5.5 Eli Lilly Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Injection Peptide Drug Introduction
11.6.4 AstraZeneca Revenue in Injection Peptide Drug Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Injection Peptide Drug Introduction
11.7.4 Novartis Revenue in Injection Peptide Drug Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Injection Peptide Drug Introduction
11.8.4 AbbVie Revenue in Injection Peptide Drug Business (2017-2022)
11.8.5 AbbVie Recent Developments
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Injection Peptide Drug Introduction
11.9.4 Ipsen Revenue in Injection Peptide Drug Business (2017-2022)
11.9.5 Ipsen Recent Developments
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Injection Peptide Drug Introduction
11.10.4 Ferring Revenue in Injection Peptide Drug Business (2017-2022)
11.10.5 Ferring Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Injection Peptide Drug Introduction
11.11.4 Merck Revenue in Injection Peptide Drug Business (2017-2022)
11.11.5 Merck Recent Developments
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Injection Peptide Drug Introduction
11.12.4 The Medicines Revenue in Injection Peptide Drug Business (2017-2022)
11.12.5 The Medicines Recent Developments
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Injection Peptide Drug Introduction
11.13.4 J & J Revenue in Injection Peptide Drug Business (2017-2022)
11.13.5 J & J Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Injection Peptide Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Subcutaneous Injection
Table 4. Global Injection Peptide Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Injection Peptide Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Injection Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Injection Peptide Drug Market Share by Region (2017-2022)
Table 8. Global Injection Peptide Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Injection Peptide Drug Market Share by Region (2023-2028)
Table 10. Injection Peptide Drug Market Trends
Table 11. Injection Peptide Drug Market Drivers
Table 12. Injection Peptide Drug Market Challenges
Table 13. Injection Peptide Drug Market Restraints
Table 14. Global Injection Peptide Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Injection Peptide Drug Revenue Share by Players (2017-2022)
Table 16. Global Top Injection Peptide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2021)
Table 17. Ranking of Global Top Injection Peptide Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Injection Peptide Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Injection Peptide Drug Product Solution and Service
Table 21. Date of Enter into Injection Peptide Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Injection Peptide Drug Revenue Market Share by Type (2017-2022)
Table 25. Global Injection Peptide Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Injection Peptide Drug Revenue Market Share by Type (2023-2028)
Table 27. Global Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Injection Peptide Drug Revenue Share by Application (2017-2022)
Table 29. Global Injection Peptide Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Injection Peptide Drug Revenue Share by Application (2023-2028)
Table 31. North America Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Injection Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Injection Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Injection Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Injection Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Injection Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Injection Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Injection Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Injection Peptide Drug Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Injection Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Injection Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Injection Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Injection Peptide Drug Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Injection Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Injection Peptide Drug Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Injection Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Injection Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Injection Peptide Drug Product
Table 64. Sanofi Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 65. Sanofi Recent Developments
Table 66. Teva Company Details
Table 67. Teva Business Overview
Table 68. Teva Injection Peptide Drug Product
Table 69. Teva Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 70. Teva Recent Developments
Table 71. Novo Nordisk Company Details
Table 72. Novo Nordisk Business Overview
Table 73. Novo Nordisk Injection Peptide Drug Product
Table 74. Novo Nordisk Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 75. Novo Nordisk Recent Developments
Table 76. Takeda Company Details
Table 77. Takeda Business Overview
Table 78. Takeda Injection Peptide Drug Product
Table 79. Takeda Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 80. Takeda Recent Developments
Table 81. Eli Lilly Company Details
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Injection Peptide Drug Product
Table 84. Eli Lilly Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 85. Eli Lilly Recent Developments
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Injection Peptide Drug Product
Table 89. AstraZeneca Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 90. AstraZeneca Recent Developments
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Injection Peptide Drug Product
Table 94. Novartis Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 95. Novartis Recent Developments
Table 96. AbbVie Company Details
Table 97. AbbVie Business Overview
Table 98. AbbVie Injection Peptide Drug Product
Table 99. AbbVie Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 100. AbbVie Recent Developments
Table 101. Ipsen Company Details
Table 102. Ipsen Business Overview
Table 103. Ipsen Injection Peptide Drug Product
Table 104. Ipsen Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 105. Ipsen Recent Developments
Table 106. Ferring Company Details
Table 107. Ferring Business Overview
Table 108. Ferring Injection Peptide Drug Product
Table 109. Ferring Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 110. Ferring Recent Developments
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Injection Peptide Drug Product
Table 114. Merck Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 115. Merck Recent Developments
Table 116. The Medicines Company Details
Table 117. The Medicines Business Overview
Table 118. The Medicines Injection Peptide Drug Product
Table 119. The Medicines Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 120. The Medicines Recent Developments
Table 121. J & J Company Details
Table 122. J & J Business Overview
Table 123. J & J Injection Peptide Drug Product
Table 124. J & J Revenue in Injection Peptide Drug Business (2017-2022) & (US$ Million)
Table 125. J & J Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injection Peptide Drug Market Share by Type: 2021 VS 2028
Figure 2. Intravenous Injection Features
Figure 3. Subcutaneous Injection Features
Figure 4. Global Injection Peptide Drug Market Share by Application: 2021 VS 2028
Figure 5. Cancer Case Studies
Figure 6. Metabolic Disorders Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Other Case Studies
Figure 9. Injection Peptide Drug Report Years Considered
Figure 10. Global Injection Peptide Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Injection Peptide Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Injection Peptide Drug Market Share by Region: 2021 VS 2028
Figure 13. Global Injection Peptide Drug Market Share by Players in 2021
Figure 14. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Injection Peptide Drug Revenue in 2021
Figure 16. North America Injection Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Injection Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 18. North America Injection Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 19. North America Injection Peptide Drug Market Size Share by Country (2017-2028)
Figure 20. United States Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Injection Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Injection Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 24. Europe Injection Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 25. Europe Injection Peptide Drug Market Size Share by Country (2017-2028)
Figure 26. Germany Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Injection Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Injection Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Injection Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Injection Peptide Drug Market Size Share by Region (2017-2028)
Figure 36. China Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Injection Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Injection Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Injection Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Injection Peptide Drug Market Size Share by Country (2017-2028)
Figure 46. Mexico Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Injection Peptide Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Injection Peptide Drug Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Injection Peptide Drug Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Injection Peptide Drug Market Size Share by Country (2017-2028)
Figure 52. Turkey Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Injection Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Sanofi Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 56. Teva Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 57. Novo Nordisk Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 58. Takeda Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 60. AstraZeneca Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 62. AbbVie Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 63. Ipsen Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 64. Ferring Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 65. Merck Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 66. The Medicines Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 67. J & J Revenue Growth Rate in Injection Peptide Drug Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---